Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Ageing Research Reviews|February 15, 2025
cGAS-STING targeting offers novel therapeutic opportunities in neurological diseasesHongquan Wang, Joshua S Fleishman, Shuang Wu, et al.Pharmacological Research|June 20, 2021
Differences in the prevention and control of cardiovascular and cerebrovascular diseasesChengdi Liu, Lida Du, Shoubao Wang, et al.Advances in Pharmacology (San Diego, Calif.)|February 25, 2020
Chemical and pharmacological research on the polyphenol acids isolated from Danshen: A review of salvianolic acidsGuanhua Du, Junke Song, Lida Du, et al.Pharmacology & Therapeutics|April 27, 2016
Polyphenols: Potential source of drugs for the treatment of ischaemic heart diseaseGuanhua Du, Lan Sun, Rui Zhao, et al.Pharmacology & Therapeutics|June 4, 2020
Induction of programmed necrosis: A novel anti-cancer strategy for natural compoundsJie Yu, Bingling Zhong, Qingwen Xiao, et al.Cell Proliferation|July 17, 2026
Targeting m6A Modifications Regulating Ferroptosis Offers Novel Therapy in DiseasesLida Du, Joshua S Fleishman, Shuang Wu, et al.Pharmacology & Therapeutics|July 27, 2023
Pharmacological interventions targeting α-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's diseaseLida Du, Xiaoli He, Xiaonuo Fan, et al.Pharmaceutics|September 23, 2022
Insight into the Formation of Cocrystal and Salt of Tenoxicam from the Isomer and ConformationYifei Xie, Penghui Yuan, Tianyu Heng, et al.Molecular Neurobiology|June 14, 2019
Neuroprotective Effects of AG490 in Neonatal Hypoxic-Ischemic Brain InjuryFeiya Li, Raymond Wong, Zhengwei Luo, et al.Signal Transduction and Targeted Therapy|November 17, 2024
Identifying genetic targets in clinical subtypes of Parkinson's disease for optimizing pharmacological treatment strategiesDewen Kong, Cao Li, LingYan Ma, et al.Pageof 4